People's Health Press
ISSN 2096-2738 CN 11-9370/R
  • Official WeChat

  • Official Weibo

  • Official headlines

Electronic Journal of Emerging Infectious Diseases ›› 2019, Vol. 4 ›› Issue (3): 169-172.

• Original Articles • Previous Articles     Next Articles

Talaromyces marneffei infection complications in an HIV-negative patient with lung cancer: a case report and review of literature

YANG Peng#, LIU Ping#, LI Qiu-wen, LU Yue-mei, WANG Ling-wei   

  1. Shenzhen People's Hospital, Shenzhen Institute of Respiratory Disease, The First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen Institute of Respiratory Diseases, Guangdong Shenzhen 518020, China
  • Online:2019-09-30 Published:2020-07-21

Abstract: Objective To analyze the clinical recognition of talaromyces marneffei infection complications in an HIV-negative patient with lung cancer in clinical manifestations, diagnosis and treatment. Methods The clinical manifestations, pathological characteristic, imaging manifestations, diagnosis, the therapy and review of literature of a patient with talaromyces marneffei infection complications in an HIV-negative patient with lung cancer were presented. Results The HIV-negative patient was a 52-year-old male, with cough, expectoration, dyspnea and wasting as the main symptom. Themicrobes of sputum culture were Talaromyces marneffei. The pulmonary nodule in the right upper lobe was pathologically confirmed as lung adenocarcinoma.Combined with the clinical symptoms, the patient was diagnosed as lung adenocarcinoma with Talaromycosis marneffei. Conclusion Patients with non-HIV immunocompromised are high-risk groups of Marneffeinosis, which are clinically lack of characteristics. It can cause multiple organ damages and is easy to be misdiagnosed. For patients with life history in epidemic areas or immunocompromised patients, they should be alert to whether it is Talaromyces marneffei infection and make diagnosis and treatment as soon as possible.

Key words: Lung cancer, Talaromyces marneffei, Non-HIV